1. Targeting Nonsense Mutations in Diseases with Translational Read-Through-Inducing Drugs (TRIDs)

   • Kerstin Nagel-Wolfrum
   • Fabian Möller
   • Uwe Wolfrum

   Leading Article 17 February 2016 Pages: 49 - 74

   

2. Trastuzumab in the Treatment of Breast Cancer

   • Sofia Maximiano
   • Paulo Magalhães
   • Manuel Morgado

   Review Article 18 February 2016 Pages: 75 - 86

   

3. Management of Multiple Myeloma with Second-Generation Antibody-Drug Conjugates

   • Pawel Robak
   • Tadeusz Robak

   Review Article 29 February 2016 Pages: 87 - 93

4. Anti-EGFR Therapy for Metastatic Colorectal Cancer in the Era of Extended RAS Gene Mutational Analysis

   • Elie Kassouf
   • Samer Tabchi
   • Mustapha Tehfe

   Review Article 29 February 2016 Pages: 95 - 104

   

5. The Challenge of Treating Early-Stage Rheumatoid Arthritis: The Contribution of Mixed Treatment Comparison to Choosing Appropriate Biologic Agents

   • Alberto Migliore
   • Emanuele Bizzi
   • Davide Integlia

   Systematic Review 23 February 2016 Pages: 105 - 115

   

6. Expression and Purification of Neurotrophin-Elastin-Like Peptide Fusion Proteins for Neural Regeneration

   • Tamina Johnson
   • Piyush Koria

   Original Research Article 28 January 2016 Pages: 117 - 127

   

7. Combination Therapy with AKT3 and PI3KCA siRNA Enhances the Antitumor Effect of Temozolomide and Carmustine in T98G Glioblastoma Multiforme Cells

   • Monika Paul-Samojedny
   • Adam Pudełko
   • Jan Kowalski

   Original Research Article 22 February 2016 Pages: 129 - 144

   

8. Healthcare Provider Type and Switch to Biologics in Psoriasis: Evidence from Real-World Practice

   • Paul S. Calara
   • Jenny M. Norlin
   • Marcus Schmitt-Egenolf

   Original Research Article 16 February 2016 Pages: 145 - 151

   

9. Tbo-Filgrastim: A Review in Neutropenic Conditions

   • Hannah A. Blair
   • Lesley J. Scott

   Adis Drug Evaluation 29 March 2016 Pages: 153 - 160